
Andrew D. Kosar
Supervisory Patent Examiner (ID: 3929, Phone: (571)272-0913 , Office: P/1625 )
| Most Active Art Unit | 1654 |
| Art Unit(s) | 1654, 1625, 1622, 1600 |
| Total Applications | 948 |
| Issued Applications | 292 |
| Pending Applications | 355 |
| Abandoned Applications | 304 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 4970691
[patent_doc_number] => 20070110693
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-05-17
[patent_title] => 'COMPOSITIONS CONTAINING PEPTIDE COPPER COMPLEXES AND SOFT TISSUE FILLERS, AND METHODS RELATED THERETO'
[patent_app_type] => utility
[patent_app_number] => 11/555602
[patent_app_country] => US
[patent_app_date] => 2006-11-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4836
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0110/20070110693.pdf
[firstpage_image] =>[orig_patent_app_number] => 11555602
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/555602 | COMPOSITIONS CONTAINING PEPTIDE COPPER COMPLEXES AND SOFT TISSUE FILLERS, AND METHODS RELATED THERETO | Oct 31, 2006 | Abandoned |
Array
(
[id] => 5215669
[patent_doc_number] => 20070104750
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-05-10
[patent_title] => 'Pesticidally active compositions having enhanced activity'
[patent_app_type] => utility
[patent_app_number] => 11/591070
[patent_app_country] => US
[patent_app_date] => 2006-11-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 7889
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0104/20070104750.pdf
[firstpage_image] =>[orig_patent_app_number] => 11591070
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/591070 | Pesticidally active compositions having enhanced activity | Oct 31, 2006 | Abandoned |
Array
(
[id] => 7688634
[patent_doc_number] => 20070106064
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-05-10
[patent_title] => 'Solid phase method for synthesis peptide-spacer-lipid conjugates, conjugates synthesized thereby and targeted liposomes containing the same'
[patent_app_type] => utility
[patent_app_number] => 11/585620
[patent_app_country] => US
[patent_app_date] => 2006-10-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15246
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0106/20070106064.pdf
[firstpage_image] =>[orig_patent_app_number] => 11585620
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/585620 | Solid phase method for synthesis peptide-spacer-lipid conjugates, conjugates synthesized thereby and targeted liposomes containing the same | Oct 23, 2006 | Abandoned |
Array
(
[id] => 92208
[patent_doc_number] => 07737114
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-06-15
[patent_title] => 'Didemnin analogs and fragments and methods of making and using them'
[patent_app_type] => utility
[patent_app_number] => 11/580239
[patent_app_country] => US
[patent_app_date] => 2006-10-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 55
[patent_figures_cnt] => 56
[patent_no_of_words] => 25222
[patent_no_of_claims] => 50
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/737/07737114.pdf
[firstpage_image] =>[orig_patent_app_number] => 11580239
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/580239 | Didemnin analogs and fragments and methods of making and using them | Oct 12, 2006 | Issued |
Array
(
[id] => 5337850
[patent_doc_number] => 20090054314
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-02-26
[patent_title] => 'Combined use of DPP-IV inhibitors and gastrin compounds'
[patent_app_type] => utility
[patent_app_number] => 11/545025
[patent_app_country] => US
[patent_app_date] => 2006-10-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28281
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0054/20090054314.pdf
[firstpage_image] =>[orig_patent_app_number] => 11545025
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/545025 | Combined use of DPP-IV inhibitors and gastrin compounds | Oct 5, 2006 | Abandoned |
Array
(
[id] => 71788
[patent_doc_number] => 07754688
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-07-13
[patent_title] => 'Methods of using retro-inverso peptides derived from interleukin-6'
[patent_app_type] => utility
[patent_app_number] => 11/544507
[patent_app_country] => US
[patent_app_date] => 2006-10-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6674
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/754/07754688.pdf
[firstpage_image] =>[orig_patent_app_number] => 11544507
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/544507 | Methods of using retro-inverso peptides derived from interleukin-6 | Oct 4, 2006 | Issued |
Array
(
[id] => 71784
[patent_doc_number] => 07754685
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-07-13
[patent_title] => 'Methods and pharmaceutical compositions for the treatment and prevention of hepatitis C infection'
[patent_app_type] => utility
[patent_app_number] => 11/542930
[patent_app_country] => US
[patent_app_date] => 2006-10-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 22563
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/754/07754685.pdf
[firstpage_image] =>[orig_patent_app_number] => 11542930
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/542930 | Methods and pharmaceutical compositions for the treatment and prevention of hepatitis C infection | Oct 1, 2006 | Issued |
Array
(
[id] => 5242829
[patent_doc_number] => 20070021324
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-01-25
[patent_title] => 'Process for preparation of mixtures of polypeptides using purified hydrobromic acid'
[patent_app_type] => utility
[patent_app_number] => 11/529668
[patent_app_country] => US
[patent_app_date] => 2006-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6462
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0021/20070021324.pdf
[firstpage_image] =>[orig_patent_app_number] => 11529668
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/529668 | Process for preparation of mixtures of polypeptides using purified hydrobromic acid | Sep 26, 2006 | Abandoned |
Array
(
[id] => 7688947
[patent_doc_number] => 20070105751
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-05-10
[patent_title] => 'Use of NF-kB Inhibition in Combination Therapy for Cancer'
[patent_app_type] => utility
[patent_app_number] => 11/535738
[patent_app_country] => US
[patent_app_date] => 2006-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 8520
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0105/20070105751.pdf
[firstpage_image] =>[orig_patent_app_number] => 11535738
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/535738 | Use of NF-κB inhibition in combination therapy for cancer | Sep 26, 2006 | Issued |
Array
(
[id] => 131699
[patent_doc_number] => 07700545
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-04-20
[patent_title] => 'Use of NF-κB inhibition in combination therapy for cancer'
[patent_app_type] => utility
[patent_app_number] => 11/535720
[patent_app_country] => US
[patent_app_date] => 2006-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 8
[patent_no_of_words] => 8628
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 134
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/700/07700545.pdf
[firstpage_image] =>[orig_patent_app_number] => 11535720
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/535720 | Use of NF-κB inhibition in combination therapy for cancer | Sep 26, 2006 | Issued |
Array
(
[id] => 4533712
[patent_doc_number] => 07871981
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-01-18
[patent_title] => 'Inhibition of cell motility, angiogenesis, and metastasis'
[patent_app_type] => utility
[patent_app_number] => 11/525672
[patent_app_country] => US
[patent_app_date] => 2006-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 25
[patent_no_of_words] => 16326
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/871/07871981.pdf
[firstpage_image] =>[orig_patent_app_number] => 11525672
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/525672 | Inhibition of cell motility, angiogenesis, and metastasis | Sep 21, 2006 | Issued |
Array
(
[id] => 5172397
[patent_doc_number] => 20070072830
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-03-29
[patent_title] => 'Methods for treating diabetes'
[patent_app_type] => utility
[patent_app_number] => 11/522105
[patent_app_country] => US
[patent_app_date] => 2006-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 17189
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0072/20070072830.pdf
[firstpage_image] =>[orig_patent_app_number] => 11522105
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/522105 | Methods for treating diabetes | Sep 14, 2006 | Abandoned |
Array
(
[id] => 4704105
[patent_doc_number] => 20080063628
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-03-13
[patent_title] => 'METHODS TO PROMOTE CELL DIFFERENTIATION'
[patent_app_type] => utility
[patent_app_number] => 11/530622
[patent_app_country] => US
[patent_app_date] => 2006-09-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 40145
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0063/20080063628.pdf
[firstpage_image] =>[orig_patent_app_number] => 11530622
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/530622 | METHODS TO PROMOTE CELL DIFFERENTIATION | Sep 10, 2006 | Abandoned |
Array
(
[id] => 5688910
[patent_doc_number] => 20060287225
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-12-21
[patent_title] => 'Integrin inhibitors for the treatment of eye diseases'
[patent_app_type] => utility
[patent_app_number] => 11/510596
[patent_app_country] => US
[patent_app_date] => 2006-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8985
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0287/20060287225.pdf
[firstpage_image] =>[orig_patent_app_number] => 11510596
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/510596 | Integrin inhibitors for the treatment of eye diseases | Aug 27, 2006 | Issued |
Array
(
[id] => 4652214
[patent_doc_number] => 20080039470
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-02-14
[patent_title] => 'Acylaminoheteroaryl hepatitis C virus protease inhibitors'
[patent_app_type] => utility
[patent_app_number] => 11/503502
[patent_app_country] => US
[patent_app_date] => 2006-08-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13773
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0039/20080039470.pdf
[firstpage_image] =>[orig_patent_app_number] => 11503502
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/503502 | Acylaminoheteroaryl hepatitis C virus protease inhibitors | Aug 10, 2006 | Issued |
Array
(
[id] => 71790
[patent_doc_number] => 07754690
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-07-13
[patent_title] => 'Method of using retro inverso peptides derived from leukemia inhibitory factor'
[patent_app_type] => utility
[patent_app_number] => 11/501975
[patent_app_country] => US
[patent_app_date] => 2006-08-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5289
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/754/07754690.pdf
[firstpage_image] =>[orig_patent_app_number] => 11501975
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/501975 | Method of using retro inverso peptides derived from leukemia inhibitory factor | Aug 8, 2006 | Issued |
Array
(
[id] => 5183500
[patent_doc_number] => 20070054854
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-03-08
[patent_title] => 'Methods of using retro-inverso peptides derived from interleukin-3'
[patent_app_type] => utility
[patent_app_number] => 11/501948
[patent_app_country] => US
[patent_app_date] => 2006-08-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6757
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0054/20070054854.pdf
[firstpage_image] =>[orig_patent_app_number] => 11501948
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/501948 | Methods of using retro-inverso peptides derived from interleukin-3 | Aug 8, 2006 | Abandoned |
Array
(
[id] => 195941
[patent_doc_number] => 07635683
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-12-22
[patent_title] => 'Quinoxalinyl tripeptide hepatitis C virus inhibitors'
[patent_app_type] => utility
[patent_app_number] => 11/499917
[patent_app_country] => US
[patent_app_date] => 2006-08-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12420
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/635/07635683.pdf
[firstpage_image] =>[orig_patent_app_number] => 11499917
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/499917 | Quinoxalinyl tripeptide hepatitis C virus inhibitors | Aug 3, 2006 | Issued |
| 61/007910 | Tetrazolyl macrocyclic hepatitis C serine protease inhibitors | Aug 3, 2006 | Pending |
| 61/007900 | Novel pyridazinonyl macrocyclic hepatitis C serine protease inhibitors | Aug 3, 2006 | Pending |